Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The story was too "uncomfortable" for local MSM to cover so instead our progressive local news outlet blame shifts pharmacy ...